ClearPoint Neuro (CLPT) Change in Receivables (2011 - 2026)
ClearPoint Neuro (CLPT) reported Change in Receivables of $2.0 million for Q1 2026, up 338.65% on a YoY basis from $460273.2 in Q1 2025, and up 163.92% sequentially from $765000.0 in Q4 2025.
ClearPoint Neuro (CLPT) Change in Receivables (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 15 years of Change in Receivables data on file, last reported at $2.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 338.65% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $3.1 million (up 159.78% YoY), and the FY2025 full-year result was $268000.0, down 77.78% from the prior year.
- Change in Receivables rose to $2.0 million in Q1 2026, from $765000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $2.0 million in Q1 2026 to a low of -$846000.0 in Q1 2024.
- A 5-year average of $324000.0 and a median of $401000.0 in 2024 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables soared 489.47% in 2023 and plunged 559.78% in 2024, its largest moves.
- Tracing CLPT's Change in Receivables over 5 years: stood at -$771000.0 in 2022, then surged by 248.12% to $1.1 million in 2023, then dropped by 8.14% to $1.0 million in 2024, then retreated by 27.07% to $765000.0 in 2025, then soared by 163.92% to $2.0 million in 2026.
- Business Quant data shows CLPT's Change in Receivables at $2.0 million in Q1 2026, $765000.0 in Q4 2025, and -$260000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | 2.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.02 Mn |
| Mar 31, 2026 | 2.02 Mn |
| Dec 31, 2025 | 765,000.00 |
| Dec 31, 2025 | 765,000.00 |
| Sep 30, 2025 | -260,000.00 |
| Sep 30, 2025 | -260,000.00 |
| Jun 30, 2025 | 609,000.00 |
| Jun 30, 2025 | 609,000.00 |
| Mar 31, 2025 | -846,000.00 |
| Mar 31, 2025 | -846,000.00 |
| Dec 31, 2024 | 1.05 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 401,000.00 |
| Sep 30, 2024 | 401,000.00 |
| Jun 30, 2024 | 602,000.00 |
| Jun 30, 2024 | 602,000.00 |
| Mar 31, 2024 | -846,000.00 |
| Mar 31, 2024 | -846,000.00 |
| Dec 31, 2023 | 1.14 Mn |
| Dec 31, 2023 | 1.14 Mn |